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Renal ischemia/reperfusion and ATP depletion/repletion in
LLC-PK1 cells result in phosphorylation of FKHR and
FKHRL1.
Background. Cell death and survival pathways are critical
determinants of epithelial cell fate after ischemia. Forkhead
proteins have been implicated in the regulation of cellular
survival.
Methods and Results. We have found that none of the fork-
head family of proteins, FKHR, is phosphorylated after isch-
emia/reperfusion in the rat kidney. The time course of phos-
phorylation is similar to the time course of activation of the
forkhead protein kinase Akt/protein kinase B (PKB), with
maximal phosphorylation at 24 to 48 hours postreperfusion
when the process of regeneration peaks. Extracellular signal-
regulated kinase (ERK)1/2 activation has also been implicated
as prosurvival in the injured kidney. ERK1/2 were phosphory-
lated in postischemic kidneys at 5, 30, and 90 minutes of reperfu-
sion, with phosphorylation decreased by 24 and 48 hours. Immu-
nocytochemical analysis revealed increased phospho-ERK1/2 in
the thick ascending limb and isolated cells of the S3 segment,
which have lost apical actin staining. To understand the relation-
ship between forkhead phosphorylation, Akt, and ERK1/2, an
in vitro model of injury was employed. After 40 minutes of
chemical anoxia followed by dextrose addition for 20 minutes
to replete adenosine triphosphate (ATP) levels, FKHR and
FKHRL1 are phosphorylated. The levels of phospho-Akt are
increased for at least 120 minutes after dextrose addition with
a maximum at 20 minutes. Phosphorylation of Akt, FKHR,
and FKHRL1 are phosphatidylinositol 3-kinase (PI 3-kinase)
dependent since phosphorylation is reduced by the PI 3-kinase
inhibitors, wortmannin, or LY294002. Inhibition of mitogen-
activated protein kinase (MAPK)/ERK kinase (MEK1/2), the
upstream activator of ERK1/2, has no effect on forkhead protein
phosphorylation after chemical anoxia/dextrose addition.
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Conclusion. We conclude that PI 3-kinase and Akt are acti-
vated after renal ischemia/reperfusion and that Akt phosphory-
lation leads to phosphorylation of FKHR and FKHRL1, which
may affect epithelial cell fate in acute renal failure.
It is important to understand the intracellular signaling
pathways that are involved in renal ischemic injury and
repair. Acute renal failure remains a common disorder
in hospitalized patients, with a high prevalence in pa-
tients in critical care units [1] and a high morbidity and
mortality [2]. Since signaling pathways can modulate cel-
lular injury [3–5], it is important to characterize those
pathways most influential in the determination of cell
fate. Once these pathways are characterized it may be
possible to block a cell death pathway and, by so doing,
modify the extent of injury, thereby preventing renal
necrosis and possibly the clinical consequences of isch-
emic acute renal failure. Alternatively, stimulation of a
pathway important for cell proliferation may be benefi-
cial to the recovery of the organ.
Forkhead proteins are transcription factors involved
in the regulation of cellular survival and cell cycle con-
trol. The three forkhead (or Fox) proteins, FKHRL1
(FOXO3a), FKHR (FOXO1a), and AFX (FOXO4), be-
longing to the “O” subfamily of the Fox proteins, contain
the “forkhead” DNA-binding domain and the conserved
Akt phosphorylation sites. These three members are
phosphorylated at several serines and one threonine by
Akt [6–9]. It is unclear whether all three members of
this family have distinct or redundant functions. DAF-16,
a forkhead transcription factor in Caenorhabditis eleg-
ans, is negatively regulated by Akt. [10]. DAF-16 is acti-
vated by both DAF-2 and DAF-23. The latter (DAF-23)
is a phosphatidylinositol 3-kinase (PI 3-kinase)-like pro-
tein [6]. The mammalian orthologs of DAF-16 are AFX,
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forkhead response element (FKHR) and FKHRL1. All
these three members (FKHRL1, FKHR, and AFX) share
a forkhead 100 amino acid core domain, responsible
for binding to DNA. AFX, FKHR, and FKHRL1 each
contain three sites that can be phosphorylated by Akt
in mammalian cells [4, 6–9].
In addition, FKHRL1 (FOXO3a) induces G1 arrest
and G2-M delay in the cell cycle [11]. Overexpression of
FKHRL1 or FKHR results in apoptosis [9, 12]. Upon
phosphorylation, Akt translocates to the nucleus where
it can phosphorylate forkhead proteins. A large variety
of physiologic stimuli increase Akt activity, primarily
due to activation of PI 3-kinase [4]. Downstream targets
of the Akt pathway include several members of the fork-
head family of transcription factors [13]. Thus, activated
Akt, which is well known to contribute to cellular sur-
vival and cell proliferation, may do so by phosphorylating
forkhead proteins [4, 13].
The mitogen-activated protein kinases (MAPKs) are
Ser/Thr kinases, which convert extracellular stimuli to
intracellular signals that control gene expression [14].
Extracellular signal-regulated kinases (ERKs), which
are members of the MAPK family, are rapidly activated
upon the stimulation of cell surface receptors and play
an important role in proliferation and differentiation
[15]. Moreover, ERKs phosphorylate and activate nu-
clear proteins [16], including Elk-1 [17], that control the
expression of c-fos and other genes, which are known
to be regulated with ischemic injury [18]. The ERKs have
been implicated in the regulation of Foxc2, a forkhead
protein gene, in adipocytes [19]. The ERK pathway has
been implicated as a modulator of ischemia/reperfusion
injury in the kidney [20] and other organs [21].
Our study was designed to investigate whether the
forkhead proteins are phosphorylated by ischemia/
reperfusion in vivo. After finding that FKHR was phos-
phorylated, we then examined the activation patterns of
Akt/protein kinase B (PKB) and ERK1/2 as potential
regulators of forkhead phosphorylation. In order to clarify
the signaling pathways resulting in forkhead protein phos-
phorylation, we used the model of chemical axoxia involv-
ing LLC-PK1 cell exposure to cyanide and 2-deoxyglucose
in the absence of dextrose, followed by adenosine tri-
phosphate (ATP) repletion by addition of dextrose in
vitro [22]. Using this model, we determined the effects of
inhibitors of the PI 3-kinase/Akt and mitogen-activated
protein kinase (MAP)/ERK kinase (MEK) pathways on
forkhead protein phosphorylation, which we found to be
increased after chemical anoxia/dextrose addition.
METHODS
Animal preparation
All experiments were performed in Sprague-Dawley
rats weighing 180 to 250 g. The rats were allowed free
access to water and standard rat chow. Plasma creatinine
was determined prior to the experiment. Animals, four
in total for each time point (sham included), were anaes-
thetized with sodium pentobarbital (50 mg/kg intraperi-
toneally) and 2 mL of 0.9% NaCl (37C) administered
on the day of surgery. The body temperature was main-
tained at 36.0C to 37.5C throughout the procedure.
Kidneys were exposed through flank incisions. The rats
were subjected to bilateral ischemia by clamping both
renal pedicles with nontraumatic microaneurysm clamps
(Roboz Surgical Instrument, Inc., Gaithersburg, MD,
USA) or underwent sham surgery as previously reported
[23, 24]. The incisions were temporarily closed during
ischemia or sham surgery. After 30 minutes of ischemia,
the clamps were removed and prompt reperfusion to the
superficial cortex of the kidneys was visually confirmed.
Kidneys of experimental groups were harvested after
either 5, 30, 90 minutes, 24, or 48 hours of reperfusion
after ischemia. The kidneys were snap frozen in liquid
nitrogen and subsequently used for Western Blot analysis
or were perfusion-fixed to perform immunohistochemistry
as previously described [25].
Chemical anoxia
The experiments with LLC-PK1 cells were performed on
confluent cells. LLC-PK1 cells were grown in Dulbecco’s
modified Eagle’s medium (DMEM) with 10% of fetal calf
serum (FCS) at 37C in 95% air, 5% CO2. Chemical anoxia
was induced as previously described [22]. Briefly, the cells
(two “10 cm dishes”/condition) were incubated in a Krebs-
Henseleit (KH) buffer (115 mmol/L NaCl, 3.6 mmol/L
KCl, 1.3 mmol/L KH2PO4, 25 mmol/L NaHCO3, 1 mmol/L
CaCl2, 1 mmol/L MgCl2, pH  7.4) with or without so-
dium cyanide (5 mmol/L) and 2-deoxyglucose (5 mmol/L)
in the absence of dextrose to induce chemical anoxia.
After 40 minutes, the cells were washed once with KH
buffer and incubated with KH buffer containing 10 mmol/L
dextrose for 0, 20, 60, and 120 minutes. Control cells
were exposed only to KH buffer for 40 minutes, and then
KH buffer with dextrose at the same concentration and
conditions of the cells previously exposed to chemical
anoxia. All the incubations were performed at 37C, in a
95% air, 5% CO2 incubator. In some cases wortmannin
(Sigma Chemical Co., St. Louis, MO USA), LY 294002
(Sigma Chemical Co.), both inhibitors of PI 3-kinase, or
PD 098059 (Sigma Chemical Co.), an inhibitor of MEK1/2,
was added at the initiation of chemical anoxia and main-
tained throughout the period of dextrose addition.
Western blot analysis
Protein lysates from rat kidneys were prepared as
previously described [22]. LLC-PK1 cells at each time
point were washed with cold phosphate-buffered saline
(PBS) and then lysed in buffer containing: 20 mmol/L
HEPES (pH  7.4), 2 mmol/L ethyleneglycol tetraace-
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tic acid (EGTA), 1 mmol/L dithiothreitol (DTT), 1
mmol/L NaVO4, 1% Triton X-100, 2 mol/L leupeptin,
2 mol/L microcystin LR, 1.5 mol/L aprotinin, and 400
mol/L phenylmethylsulfonyl fluoride (PMSF). Protein
extracts were resolved by sodium dodecyl sulfate poly-
acrylamide gel electrophoresis (SDS-PAGE) and trans-
ferred to an Immobilon membrane (Millipore, Bedford.
MA, USA). The membrane was incubated for 1 hour at
room temperature with 5% nonfat powdered milk in a
TBS-Tween buffer (TBST) [20 mmol/L Tris and 137
mmol/L NaCl, pH 7.6, containing 0.1% Tween 20 (Fisher
Scientific, Atlanta, GA, USA)]. The primary antibody,
diluted in TBST with 5% nonfat powdered milk, was
then added to the membrane and allowed to incubate
overnight at 4C. The membrane was washed three times,
10 minutes each, at room temperature with TBST and
then incubated at room temperature for 1 hour with a
secondary antibody conjugated with horseradish peroxi-
dase (Dako Corporation, Carpinteria, CA, USA), di-
luted 1:5000 in the TBST with 1% nonfat powdered milk.
The membrane was washed as above (i.e., three times).
The secondary antibodies, conjugated with horseradish
peroxidase, were detected by the enhanced chemilumi-
nescence system (NEN Life Science Products, Boston,
MA, USA) according to the manufacturer’s instructions.
The primary antibodies included antiphospho-ERK1/2
(p44/p42 MAP kinase) (Cell Signaling, Beverly, MA,
USA); antitotal ERK (p44/42 MAP kinase) (Santa Cruz
Biotechnologies, Santa Cruz, CA, USA); antiphospho-
Akt (Ser 473) (Cell Signaling); antitotal Akt (Cell Signal-
ing); antiphospho-JNK1/2 (Promega, Madison, WI, USA);
antiphospho-FKHR (Ser 256) (Cell Signaling); antiphos-
pho-FKHRL1 (Thr 32)/antiphospho-FKHR (Thr 24) (Cell
Signaling); antitotal FKHR (Santa Cruz Biotechnologies);
antitotal FKHRL1 (Santa Cruz Biotechnologies); anti-
phospho-AFX (Ser 193) (Cell Signaling); and antitotal
FasL (BD Transduction Labs, San Jose, CA, USA).
Immunocytochemistry
To assess the anatomic distribution of proteins, rat
kidneys were fixed and processed as previously described
[25]. The sections were dried and then washed for 5
minutes at room temperature in PBS (137 mmol/L NaCl,
27 mmol/L KCl, 10 mmol/L Na2HPO4, 1.76 mmol/L
KH2PO4) with 0.1% SDS followed by an incubation for
10 minutes in PBS alone. The sections were incubated
with a solution (“blocking solution”) of 2% bovine serum
albumin (BSA) in PBS, and then incubated with a pri-
mary antibody overnight at 4C. As a negative control,
serial sections were exposed only to the “blocking solu-
tion.” The sections were then washed twice in a solution
of PBS containing 1.9% NaCl for 5 minutes (each wash)
followed by another wash in PBS alone. Subsequently,
the appropriate secondary antibody was used. After 1
hour of incubation under light protection at room tem-
perature, the sections were washed again as above and
the nuclei were counterstained with 4,6 diamidino-2-
phenylindole (DAPI) for 30 minutes at room tempera-
ture. All sections were covered with Vectashield (Vector
Laboratories, Burlingame, CA, USA) before coverslips
were applied. The primary antibodies used for immuno-
cytochemistry were polyclonal rabbit antiphospho-ERK
(1:100 dilution) (Cell Signaling); monoclonal mouse anti-
gp 330/megalin culture supernatant, diluted 1:8 (pro-
vided by Dr. R.T. McCluskey, Massachusetts General
Hospital, Boston, MA, USA). The secondary antibodies
used were Cy3 labeled donkey antirabbit immunoglobu-
linG (IgG) (Jackson ImmunoResearch Laboratories, Inc.,
West Grove, PA, USA) and fluorescein isothiocyanate
(FITC)-labeled goat antimouse IgG (Sigma Chemical
Co.). In some experiments, after application of the sec-
ondary antibody, the sections were incubated with FITC-
labeled phalloidin (Sigma Chemical Co., 1:80 dilution)
for 20 minutes and then washed three times for 5 minutes
with PBS to identify the actin cytoskeleton. Images were
viewed on a Nikon FXA fluorescence microscope and
collected using a digital camera (Hamamatsu Corp.,
Bridgewater, NJ, USA). In some cases images were
merged by using IP Lab spectrum software. All experi-
ments described in this manuscript were repeated at least
three times with similar results.
RESULTS
FKHR and Akt/PKB phosphorylation following
renal ischemia/reperfusion
Thirty minutes of transient bilateral ischemia was in-
duced in rats. The kidneys were isolated at 5, 30, and 90
minutes, and at 24 and 48 hours postischemia. Western
analysis of total lysates from these kidneys revealed an
increase in phosphorylation of FKHR at Ser 256 at 5,
30, and 90 minutes and 24 and 48 hours of reperfusion
with a maximum at 24 hours (Fig. 1A). Since FKHR is
known to be a target of Akt, we evaluated the activation
pattern of Akt by using an antibody specific for phos-
phorylation at Ser 473. An increase in Akt phosphoryla-
tion followed a similar pattern to that of FKHR phos-
phorylation (Fig. 1B), with an increase present at each
time point and a maximal level of phosphorylation at 24
hours of reperfusion.
Effect of renal ischemia/reperfusion
on ERK1/2 phosphorylation
Like FKHR and Akt, there is increased phosphoryla-
tion of ERK1/2 at each postischemic time point when
compared to sham controls (Fig. 1C). By contrast with
the pattern seen with FKHR and Akt, however, levels
of ERK1 and 2 phosphorylation are highest at 5 and 30
minutes, and then decrease.
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Fig. 1. Activation of forkhead (FKHR), Akt/protein kinase B (PKB),
and extracellular signal-regulated kinase (ERK)1/2 in the rat kidney
following bilateral ischemia/reperfusion. Western blots were performed
using whole rat kidney lysates taken from kidneys that had been sub-
jected to an initial period of 30 minutes of bilateral ischemia (I) followed
by 5, 30, 90 minutes, 24 hours or 48 hours of reperfusion or sham (S)
operation. The same tissue lysates were analyzed for FKHR, Akt/
PKB, and ERK1/2. (A ) Western Blot using a phospho-specific FKHR
antibody (p-FKHR) (Ser 256) and FKHR antibody. (B ) Western blot
using a phospho specific Akt antibody (p-Akt) (Ser 473) or antitotal
Akt antibodies. (C ) Western blot using a dual phospho-specific ERK1/2
antibody (p-ERK) or antibody that recognizes total ERK1 and ERK2.
Immunocytochemical analysis of phospho-ERK1/2
and phalloidin in kidneys following renal
ischemia/reperfusion
It was not possible to localize the phosphorylated
FKHR or Akt given the available antibodies. We were,
however, successful in identifying the structures in which
phosphorylated ERK1/2 is increased postischemia. The
immunocytochemical staining pattern of sham-operated
kidneys revealed phospho-ERK1/2 staining in a subpop-
ulation of cells in the thick ascending limbs in the outer
and inner stripe of the outer medulla. At 30 minutes
postreperfusion, many more thick ascending limb cells
stain positively for phospho-ERK1/2. There is an occa-
sional S3 segment proximal tubule cell that also stains
positively for phospho-ERK1/2 in the outer stripe of
the outer medulla (Fig. 2). The proximal tubules were
identified by positive staining for gp 330. There are more
S3 segment cells that are stained with the phospho-
ERK1/2 antibody at 5 minutes postischemia, although
the positively staining cells remained a distinct minority
of S3 segment cells (Fig. 3). In order to identify whether
the S3 cells that expressed phospho-ERK1/2 were char-
acterized by other changes in protein expression that
might provide insight into whether the stained cells were
more or less injured by the ischemia/reperfusion, we used
FITC-phalloidin to stain the actin cytoskeleton. Actin
staining is much less intense in cells staining for phospho-
ERK1/2 when compared to phospho-ERK1/2–negative
cells in the same tubules (Fig. 3). Loss of normal actin
staining is characteristic of cells that have suffered loss
of polarity due to ischemia/reperfusion [26]. Our data
show clearly that phospho-ERK is up-regulated in those
cells of the S3 segment (arrows) in which loss of polarity,
as reflected by more pronounced loss of apical actin
staining, is most pronounced in the early postischemic
period.
Forkhead protein, Akt, and ERK phosphorylation
after chemical anoxia
In order to evaluate whether the PI 3-kinase/Akt and
ERK1/2 signaling pathways are involved in forkhead
protein phosphorylation at Ser 256 with ischemia/reper-
fusion, we used a model of chemical anoxia followed by
dextrose addition to mimic aspects of ischemia/reperfu-
sion in vitro, as previously described [22]. We initially deter-
mined whether we could recapitulate in vitro the phosphor-
ylation of FKHR seen in the rat kidney after ischemia/
reperfusion in vivo. FKHR phosphorylation in LLC-PK1
cells occurs maximally at 20 minutes of dextrose addition
following chemical anoxia and then decreases over time
(Fig. 4A). We also investigated FKHRL1, another fork-
head family member. Western blot analysis was per-
formed using an antibody that recognizes FKHRL1 that
is phosphorylated at Thr 32 (p-FKHRL1) and FKHR
that is phosphorylated at Thr 24 (p-FKHR) (Fig. 4B).
After 40 minutes’ exposure to deoxyglucose and cyanide
(time  0), just prior to dextrose addition, there is ab-
sence of phosphorylation of both FKHR (Fig. 4 A and B)
and FKHRL1 (Fig. 4B) as might be predicted due to the
cyanide/deoxyglucose-induced ATP depletion. Consis-
tent with this loss of phosphorylation, there is an increase
in electrophoretic mobility of FKHRL1 (Fig. 4C), com-
patible with stoichiometric dephosphorylation of the pro-
tein. After subsequent dextrose exposure for 20 minutes,
there is decreased electrophoretic mobility of FKHRL1
compared to controls, indicating that the protein may
be hyperphosphorylated. Phosphorylation and decreased
mobility are prevented by wortmannin or LY294002,
indicating that this phosphorylation event is PI 3-kinase-
dependent. Extracts from cells treated with wortmannin
or LY294002 also showed decreased intensities of the
FKHRL1 band indicating that the expression of this tran-
scription factor may be PI 3-kinase-dependent. A similar
pattern is also seen after 60 minutes of dextrose addition,
but the electrophoretic shift is less marked indicating less
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Fig. 2. Immunohistochemistry of phospho-
extracellular signal-regulated kinase (p-ERK)
(red) and the proximal tubule cell apical mem-
brane marker gp 330/megalin (green) in the
kidneys of sham-operated rats (A and C ) or
in rat kidneys after 30 minutes of reperfusion
after ischemia (B and D ). In the kidneys of
sham-operated rats there is p-ERK staining
of individual cells in collecting ducts (CD)
both in the outer stripe (A) and the inner
stripe (C) of the outer medulla. The border
of outer and inner stripe is depicted in (C)
and (D) with the presence of some gp 330-
labeled S3 outer stripe proximal tubules (PT).
After ischemia, p-ERK staining is markedly
increased in both the medullary thick as-
cending limbs (TAL) and the interstitium. The
same results (not shown) were obtained in
kidney reperfused for 5 minutes. The hori-
zontal white line indicates a length of 50 m.
Fig. 3. Double staining of phospho-extracel-
lular signal-regulated kinase (p-ERK) (red)
and phalloidin (a stain for the cytoskeleton
protein actin) (green) in the outer medulla of
kidneys of sham operated rats (A and B ) and
after 5 minutes of reperfusion after ischemia
(C and D ). After ischemia, individual cells of
the S3 segment of proximal tubules stain for
p-ERK in (C). These cells (arrows) show loss
of brush border actin staining (D). In sham-
operated rats no p-ERK staining of proximal
tubule cells is observed (A) and brush borders
stain normally for actin (B). The horizontal
white line indicates a length of 50 m.
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Fig. 4. Forkhead protein phosphorylation in LLC-PK1 cells at different
lengths of time after adenosine triphosphate (ATP) depletion/repletion.
Phosphorylated FKHR (p-FKHR) and phosphorylated FKHRL1
(p-FKHRL1) levels were compared in control LLC-PK1 cell extracts, and
after cells were exposed to sodium cyanide (5 mmol/L) and 2-deoxyglu-
cose (5 mmol/L) for 40 minutes, followed by dextrose addition to replete
ATP, in the presence or absence of wortmannin (Wort) (100 nmol/L) or
LY294002 (LY) (10mol/L), inhibitors of phosphatidylinositol 3-kinase
(PI 3-kinase). Whole cell lysates were immunoblotted with anti-p-
FKHR (Ser 256) antibody that recognizes phosphorylated Ser 256 of
FKHR or an anti-FKHR antibody which recognizes total FKHR (A );
anti-p-FKHRL1 (Thr 32) antibody that recognizes the phospho-Thr 32
of FKHRL1 as well as phospho-Thr 24 of FKHR (B); anti-FKHRL1
antibody, that specifically recognizes total FKHRL1 (C); anti-Fas ligand
(FasL) antibody (D); and anti-phospho-AFX (Ser 193) (E). Abbrevia-
tions are: Cy-Deox, cyanide-2-deoxyglucose; DMSO, dimethyl sulfoxide.
phosphorylation of the protein. After 2 hours of dextrose
addition, there is a small increase in phosphorylation
status and mobility of the protein, as well as total
FKHRL1, when compared with controls (Fig. 4B and C).
Interestingly, phosphorylation of FKHRL1 at Thr 32 was
not completely abolished at 20 minutes by wortmannin
or LY294002, suggesting that other pathways might con-
tribute to a minor extent to the phosphorylation of
FKHRL1 (Fig. 4B). In contrast to the effects on FKHR
and FKHRL1, there is no effect of chemical anoxia on
Fas ligand (FasL) (Fig. 4D) or phosphorylation of AFX
(Fig. 4D), another forkhead family member that has
been reported to be one of the downstream targets of
Akt [8]. The antibody used is specific for phosphorylation
at the Ser 193 site of AFX.
The temporal pattern of change in Akt phosphoryla-
tion (at Ser 473) follows closely that of the forkhead
proteins with maximal levels of Akt phosphorylation
Fig. 5. Activation of Akt/protein kinase B (PKB) pathway in LLC-
PK1 cells at different lengths of time after dextrose addition subsequent
to chemical anoxia. Each time point of the experiments had a control
achieved by incubating the LLC-PK1 cells in Krebs-Henseleit (KH)
buffer without sodium cyanide (5 mmol/L) (Cy) and 2-deoxyglucose (5
mmol/L) (Deox) for the same time period as the time period of chemical
anoxia (40 minutes) used for the tested experimental conditions. Whole
cell lysates were immunoblotted with an anti-p-Akt antibody that spe-
cifically recognizes phospho-Ser 473 of Akt/PKB (upper panel). The
phosphatidylinositol 3-kinase (PI 3-kinase)-dependent phosphorylation
of Akt at Ser 473 is demonstrated by using wortmannin (Wort) (100
nmol/L) or LY294002 (LY) (10 mol/L). Dimethyl sulfoxide (DMSO)
was used as a control for both wortmannin and LY294002, which were
both dissolved in DMSO. The Western blots were later reprobed with
an anti-Akt antibody which recognizes total Akt/PKB (lower panel).
after 20 minutes of dextrose addition following chemical
anoxia in LLC-PK1 cells. There is a decrease in mobility
of the Akt protein at 20 minutes after dextrose addition
consistent with enhanced phosphorylation (Fig. 5). Wort-
mannin (100 nmol/L) and LY294002 (10 mol/L) block
the effect of chemical anoxia followed by dextrose expo-
sure on phosphorylation of Akt, indicating that the phos-
phorylation at Ser 473 of Akt is PI 3-kinase-dependent
in LLC-PK1 cells (Fig. 5).
Chemical anoxia also results in an increase in ERK1/2
phosphorylation (p-ERK) with maximal levels measured
after 20 minutes of dextrose addition following chemical
anoxia in LLC-PK1 cells, without any change in total
ERK1/2 expression (Fig. 6A).
As a positive control, we evaluated the effect of chemi-
cal anoxia followed by dextrose exposure on c-Jun N-ter-
minal kinase (also known as “stress-activated protein
kinase”) activity, which we have reported previously [22]
to be up-regulated under these conditions in Madin-
Darby canine kidney (MDCK) cells, another renal epi-
thelial cell line. Increased levels of phospho-JNK1/2 are
found in LLC-PK1 cells at 20 minutes after dextrose
addition following 40 minutes of chemical anoxia with
levels then returning to baseline by 60 minutes (Fig. 6B).
In order to evaluate whether ERK activation is involved
in FKHR phosphorylation at Ser 256, LLC-PK1 cells
were incubated with PD098059, a MEK1/2 inhibitor, dur-
ing 20 minutes of dextrose exposure following 40 minutes
of chemical anoxia. There is no effect of MEK1/2 inhibi-
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Fig. 6. Activation of extracellular signal-regulated kinase (ERK)1/2
and JNK1/2, and phosphorylation of FKHR in LLC-PK1 cells at differ-
ent lengths of time after dextrose addition subsequent to chemical
anoxia. Each time point of the experiments had a control obtained by
incubating the LLC-PK1 cells in Krebs-Henseleit (KH) buffer without
sodium cyanide (5 mmol/L) (Cy) and 2-deoxyglucose (5 mmol/L)
(Deox) for the same time period as was used for chemical anoxia
(40 minutes). (A ) Whole cell lysates were immunoblotted with a dual
phospho-specific ERK1/2 antibody (upper panel) and subsequently re-
probed (lower level) with an anti ERK1/2 antibody to confirm equiva-
lent protein loading. (B ) Whole cell lysates were immunoblotted with
an antibody (p-JNK1/2) that specifically recognizes the dually phosphor-
ylated Thr/Pro/Tyr region (pTPpY) from the catalytic core of the active
form of JNK kinase, corresponding to the Thr 183 and Tyr 185 of the
mammalian JNK2 enzyme. (C ) Whole cell lysates were immunoblotted
with an antibody (p-FKHR) that specifically recognizes phospho-Ser
256 of FKHR, in the presence or absence of PD098059 (PD) (50
mol/L), a MEK1/2 inhibitor (upper panel). Western Blot analysis was
performed on the same samples using an anti-FKHR antibody (middle
panel) or the dual phospho-specific ERK1/2 antibody (lower panel).
tion on phosphorylation of FKHR, even though the drug
decreases the phosphorylation of ERK1/2 as expected
(Fig. 6C). Thus, ERK1/2 are not involved in FKHR phos-
phorylation in this model.
DISCUSSION
Little is known about the possible involvement of the
forkhead family proteins in ischemia. Our data show
for the first time that the phosphorylation status of two
members (FKHR and FKHRL1) of that family of tran-
scriptional factors can be altered with renal ischemia/
reperfusion and ATP depletion/repletion of renal epi-
thelial cells in vitro. FKHR is considered to be a poten-
tial nuclear target in metabolic and survival pathways.
FKHR-induced apoptosis appears to depend on its tran-
scriptional activity [12]. In its dephosphorylated state,
FKHR possesses proapoptotic activity. Tang et al [12]
have shown that the phosphorylation on some or all of
the three Akt phosphorylation sites (Thr 24, Ser 256, and
Ser 319) contributes to the down-regulation of FKHR’s
ability to activate transcription and to induce apoptosis.
Guo et al [27] have suggested that phosphorylation of
Ser 256 might disrupt interactions between FKHR and
a co-activating factor required for transactivation or in-
duce the recruitment of a co-repressor. We found that
FKHR is phosphorylated at Ser 256 and at Thr 24 upon
dextrose exposure following chemical anoxia in vitro.
Our in vivo studies showed FKHR to be phosphorylated
on Ser 256. It has recently been reported that long-term
forkhead activation causes a sustained reversible cell
cycle arrest in G0 in the absence of any increase in apo-
ptosis [28]. Mutations of FKHRL1 can lead to oncogene-
sis [29]. p27KIP1, a cell cycle inhibitor, is a forkhead target
gene [30]. Under conditions of ischemia/reperfusion,
there is a very significant regenerative phase in which
the epithelial cells replace cells that have succumbed to
the insult [31].
Recently, a paper was published describing a screen
for genetic determinants of hypoxic cell death in C. eleg-
ans [32]. In C. elegans, hypoxia resistance was associated
with a loss of function mutation of daf-2, an insulin/
insulin-like growth factor homology gene, and was medi-
ated through the Akt/PDK-1/forkhead transcription fac-
tor pathway. It is noteworthy that the precise mecha-
nisms responsible for protection against hypoxic injury
were not identified in this work.
It has been suggested in several studies that Akt/PKB
might be a critical regulator of cell survival. The transfec-
tion of a variety of cell types with constitutively active
Akt alleles (and in some cases wild-type Akt) blocks
apoptosis induced by a wide range of apoptotic stimuli,
including growth factor withdrawal, ultraviolet irradia-
tion, matrix detachment, cell cycle discordance, DNA
damage, and treatment of cells with anti-Fas antibody
or transforming growth factor- (TGF-) [33–40]. Fur-
thermore, introduction of dominant-negative constructs
of Akt has been found to block the ability of a variety
of growth factors to promote survival [33, 34, 36–39, 41].
The identification of the Akt consensus phosphorylation
sequences in proteins involved in the apoptotic process
raised the possibility that Akt regulates cell survival by
directly phosphorylating components of the cell death
apparatus [42, 43]. We have found that there is increased
Andreucci et al: FKHR and FKHRL1 phosphorylation with ischemia/reperfusion1196
phosphorylation of Akt at Ser 473 (required for its maxi-
mal activity) in LLC-PK1 cells, under conditions of chem-
ical anoxia followed by dextrose exposure. Studies of
Akt/PKB activation pathways have shown that PI 3-kinase
is a mediator of an activator signal for Akt/PKB [35,
44–46]. PI 3-kinase is considered one of the intracellular
signals responsible for the transmission of anti-apoptotic
signals for controlling cell survival. Overexpression of
PI 3-kinase in cells has been shown to cause a significant
increase in survival of cells exposed to ionizing radiation
[35, 36, 46–48]. Specific inhibitors of PI 3-kinase cause
an increase in apoptosis and a decrease in cell survival
[36, 47, 49]. Akt may also be activated by a PI 3-kinase
independent mechanism as it is, for example, in response
to heat shock or increases in intracellular calcium or
cyclic adenosine monophosphate (cAMP) [41, 50–53]. The
dramatic decrease of phosphorylation of Akt at Ser 473
that we find when chemical anoxia/ATP repletion is car-
ried out in the presence of wortmannin or LY294002
suggests that Akt phosphorylation is PI 3-kinase-depen-
dent.
Other signaling molecules, which have been impli-
cated in cell survival in the postischemic kidney, include
ERK1/2. di Mari, Davis, and Safirstein [20] suggested
that increased expression of ERK in the thick ascend-
ing limb may account for the relative protection of this
segment as compared to the S3 segment [54, 55] after
ischemia/reperfusion. They measured relative levels of
ERK1/2 and JNK activation in whole tissue extracts from
inner and outer stripes of the outer medulla. The present
study identifies for the first time the specific cells in which
ERK1/2 is activated in the postischemic kidney. In our
study, the sham-operated rat kidney tissue sections show
phospho-ERK present in collecting ducts at a level simi-
lar to that seen in the postischemic kidney sections. With
ischemia/reperfusion, there is enhanced phospho-ERK1/2
levels in medullary thick ascending limb. These data
support the views of di Mari, Davis, and Safirstein [20].
We found a small subset of cells of the S3 segment that
also stain for phospho-ERK1/2. It is of interest that the
individual S3 segment cells that stain for ERK1/2 show
a marked loss of the normal actin cytoskeletal pattern.
While it would have been of interest to colocalize phos-
pho-ERK1/2 with phospho-Akt and phospho-forkhead
proteins, this will have to wait for the development of
phospho-Akt and phospho-forkhead antibodies better
suited to immunohistochemical analysis than those cur-
rently available. Since forkhead protein phosphorylation
occurs also at early time points after ischemia, as does
ERK1/2, we evaluated whether the two might be on the
same signaling pathway by determining whether inhibi-
tion of MEK1/2, which blocks ERK1/2 activation, can
prevent forkhead protein phosphorylation. The absence
of any effect of MEK1/2 inhibition indicates that the
consequences of ERK1/2 activation and forkhead phos-
Fig. 7. Schematic representation of the signaling pathways involved in
renal ischemia/reperfusion damage showing the point of action of their
respective inhibitors. Abbreviations are: MEK1/2, MAPK/ERK kinase;
PI 3-kinase, phosphatidylinositol 3-kinase; ERK1/2, extracellular signal-
regulated kinases; Atk/Atk/PKB, Atk/Atk/protein kinase B.
phorylation occur through two distinct processes. Akt/
PKB is also activated early after ischemia/reperfusion
and the PI 3-kinase pathway, of which it is a member,
is clearly involved in the phosphorylation of forkhead
proteins, as shown by our data. The maximal FKHR
phosphorylation at Ser 256 and Akt/PKB phosphoryla-
tion at Ser 473 occurs much later than that of ERK1/2,
namely, at 24 and 48 hours of kidney reperfusion.
CONCLUSION
We conclude that in the rat kidney exposed to isch-
emia/reperfusion and in LLC-PK1 renal epithelial cells
exposed to ATP depletion/repletion in vitro, there is
induction of phosphorylation of at least two forkhead
proteins, namely FKHR and FKHRL1. By contrast, the
phosphorylation status of another forkhead family mem-
ber, AFX, was not affected. Phosphorylation of Akt in
vivo and in vitro occurs with a time course closely mim-
icking that of forkhead phosphorylation. Using a model
of chemical anoxia in vitro it is clear that forkhead
protein and Akt phosphorylation are dependent upon
PI 3-kinase activation. Thus, the PI 3-kinase/Akt/FKHR
pathway (Fig. 7) represents a signaling pathway that may
be important during ischemic acute renal failure and
could potentially be a focus for therapeutic intervention.
Identification of the ultimate targets of the pathway may
help in understanding the determinants of cell fate after
an ischemic insult.
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